Ram Nagaraj
Concepts (461)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lens, Crystalline | 51 | 2024 | 125 | 13.310 |
Why?
| | Glycation End Products, Advanced | 38 | 2025 | 82 | 8.030 |
Why?
| | Crystallins | 32 | 2025 | 59 | 7.590 |
Why?
| | Lysine | 31 | 2025 | 294 | 5.230 |
Why?
| | Pyruvaldehyde | 29 | 2025 | 46 | 5.030 |
Why?
| | Cataract | 24 | 2024 | 213 | 4.650 |
Why?
| | Epithelial Cells | 17 | 2024 | 1096 | 4.260 |
Why?
| | Molecular Chaperones | 18 | 2022 | 195 | 4.090 |
Why?
| | alpha-Crystallin B Chain | 12 | 2020 | 24 | 4.000 |
Why?
| | Epithelial-Mesenchymal Transition | 8 | 2025 | 209 | 3.700 |
Why?
| | Transforming Growth Factor beta2 | 7 | 2025 | 36 | 3.520 |
Why?
| | alpha-Crystallin A Chain | 8 | 2020 | 13 | 3.030 |
Why?
| | Kynurenine | 11 | 2016 | 114 | 2.950 |
Why?
| | Arginine | 23 | 2020 | 271 | 2.750 |
Why?
| | Apoptosis | 15 | 2019 | 2553 | 2.430 |
Why?
| | Maillard Reaction | 29 | 2015 | 30 | 2.420 |
Why?
| | Presbyopia | 4 | 2023 | 15 | 2.400 |
Why?
| | Receptor for Advanced Glycation End Products | 4 | 2025 | 33 | 2.180 |
Why?
| | Lens Capsule, Crystalline | 3 | 2024 | 11 | 2.090 |
Why?
| | Capsule Opacification | 4 | 2020 | 22 | 1.910 |
Why?
| | Eye Proteins | 6 | 2018 | 92 | 1.790 |
Why?
| | alpha-Crystallins | 7 | 2019 | 13 | 1.770 |
Why?
| | Glaucoma | 3 | 2022 | 237 | 1.750 |
Why?
| | Aging | 22 | 2020 | 1864 | 1.750 |
Why?
| | Ocular Hypertension | 3 | 2025 | 69 | 1.680 |
Why?
| | Diabetes Mellitus, Experimental | 13 | 2020 | 195 | 1.630 |
Why?
| | HSP27 Heat-Shock Proteins | 4 | 2015 | 14 | 1.600 |
Why?
| | Ornithine | 11 | 2017 | 26 | 1.490 |
Why?
| | Indoleamine-Pyrrole 2,3,-Dioxygenase | 8 | 2018 | 56 | 1.430 |
Why?
| | Cysteine | 3 | 2025 | 204 | 1.410 |
Why?
| | Peptides | 5 | 2021 | 985 | 1.330 |
Why?
| | Glyoxal | 3 | 2025 | 15 | 1.310 |
Why?
| | Ascorbic Acid | 9 | 2017 | 177 | 1.280 |
Why?
| | Sirtuins | 2 | 2019 | 40 | 1.230 |
Why?
| | Sirtuin 3 | 2 | 2019 | 61 | 1.180 |
Why?
| | Cellular Senescence | 3 | 2024 | 189 | 1.080 |
Why?
| | Glutathione | 10 | 2020 | 356 | 1.080 |
Why?
| | Animals | 67 | 2025 | 36940 | 1.070 |
Why?
| | Acetylation | 9 | 2024 | 248 | 1.050 |
Why?
| | Diabetic Retinopathy | 6 | 2024 | 189 | 1.050 |
Why?
| | Cattle | 23 | 2020 | 984 | 1.030 |
Why?
| | Retinal Ganglion Cells | 4 | 2025 | 110 | 1.030 |
Why?
| | Chromatography, Liquid | 8 | 2024 | 433 | 0.990 |
Why?
| | Lactoylglutathione Lyase | 6 | 2009 | 18 | 0.980 |
Why?
| | Retinal Vessels | 7 | 2018 | 69 | 0.950 |
Why?
| | Imidazoles | 7 | 2012 | 238 | 0.950 |
Why?
| | Pyrimidines | 11 | 2017 | 470 | 0.900 |
Why?
| | Tandem Mass Spectrometry | 7 | 2024 | 532 | 0.900 |
Why?
| | Antibodies, Monoclonal | 6 | 2019 | 1430 | 0.890 |
Why?
| | Choroidal Neovascularization | 1 | 2025 | 56 | 0.890 |
Why?
| | Cells, Cultured | 18 | 2025 | 4193 | 0.870 |
Why?
| | Heat-Shock Proteins | 5 | 2022 | 143 | 0.830 |
Why?
| | Sulfhydryl Compounds | 2 | 2024 | 189 | 0.830 |
Why?
| | Pericytes | 5 | 2012 | 34 | 0.830 |
Why?
| | Ultraviolet Rays | 3 | 2017 | 396 | 0.820 |
Why?
| | Mice | 22 | 2025 | 17787 | 0.810 |
Why?
| | Tetroses | 3 | 2020 | 5 | 0.800 |
Why?
| | Blotting, Western | 13 | 2019 | 1226 | 0.800 |
Why?
| | Glucose | 14 | 2017 | 1020 | 0.790 |
Why?
| | Disease Models, Animal | 8 | 2025 | 4295 | 0.790 |
Why?
| | Eye Diseases | 2 | 2015 | 87 | 0.760 |
Why?
| | Glycosylation | 12 | 2020 | 151 | 0.750 |
Why?
| | Protein Processing, Post-Translational | 5 | 2024 | 465 | 0.740 |
Why?
| | Proteins | 9 | 2021 | 1009 | 0.730 |
Why?
| | Chromatography, High Pressure Liquid | 18 | 2010 | 597 | 0.710 |
Why?
| | Humans | 89 | 2025 | 137585 | 0.710 |
Why?
| | Kynurenine 3-Monooxygenase | 1 | 2020 | 5 | 0.660 |
Why?
| | Kynurenic Acid | 1 | 2020 | 20 | 0.660 |
Why?
| | Posterior Capsule of the Lens | 1 | 2020 | 11 | 0.650 |
Why?
| | Malonates | 1 | 2019 | 8 | 0.650 |
Why?
| | Propionates | 1 | 2019 | 39 | 0.640 |
Why?
| | Tryptophan | 7 | 2013 | 183 | 0.610 |
Why?
| | Fibrosis | 2 | 2025 | 552 | 0.600 |
Why?
| | Fibronectins | 4 | 2024 | 133 | 0.590 |
Why?
| | Diabetes Mellitus | 14 | 2024 | 1040 | 0.570 |
Why?
| | Mice, Inbred C57BL | 9 | 2025 | 5757 | 0.570 |
Why?
| | Aged | 31 | 2024 | 23961 | 0.560 |
Why?
| | Spectrometry, Fluorescence | 9 | 2012 | 168 | 0.550 |
Why?
| | Reperfusion Injury | 1 | 2020 | 279 | 0.540 |
Why?
| | Lipid Bilayers | 2 | 2010 | 98 | 0.540 |
Why?
| | Mice, Knockout | 6 | 2025 | 3015 | 0.530 |
Why?
| | Cell Line | 7 | 2020 | 2847 | 0.520 |
Why?
| | Capillaries | 4 | 2006 | 108 | 0.520 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2020 | 350 | 0.520 |
Why?
| | Immunohistochemistry | 7 | 2019 | 1738 | 0.520 |
Why?
| | Aspirin | 1 | 2020 | 387 | 0.510 |
Why?
| | Circular Dichroism | 6 | 2019 | 149 | 0.510 |
Why?
| | MAP Kinase Signaling System | 2 | 2018 | 320 | 0.510 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2018 | 278 | 0.500 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 12 | 2018 | 852 | 0.470 |
Why?
| | Endothelial Cells | 4 | 2024 | 785 | 0.470 |
Why?
| | Proteomics | 2 | 2024 | 1111 | 0.470 |
Why?
| | Cross-Linking Reagents | 10 | 2020 | 217 | 0.470 |
Why?
| | HSP20 Heat-Shock Proteins | 1 | 2015 | 2 | 0.470 |
Why?
| | Protein Aggregation, Pathological | 1 | 2015 | 21 | 0.460 |
Why?
| | Protein Structure, Tertiary | 7 | 2013 | 861 | 0.460 |
Why?
| | Pyridoxamine | 2 | 2006 | 2 | 0.460 |
Why?
| | Histones | 1 | 2020 | 636 | 0.440 |
Why?
| | Protein Structure, Secondary | 6 | 2013 | 374 | 0.440 |
Why?
| | Blood Proteins | 8 | 2009 | 252 | 0.430 |
Why?
| | Rats | 15 | 2025 | 5647 | 0.430 |
Why?
| | Brain Diseases | 1 | 2015 | 141 | 0.420 |
Why?
| | Amino Acid Sequence | 8 | 2015 | 2139 | 0.420 |
Why?
| | Inhibitor of Apoptosis Proteins | 1 | 2013 | 49 | 0.400 |
Why?
| | Solubility | 4 | 2023 | 245 | 0.400 |
Why?
| | Retina | 4 | 2025 | 298 | 0.400 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 5 | 2013 | 187 | 0.390 |
Why?
| | Pyrroles | 7 | 2009 | 213 | 0.390 |
Why?
| | Disulfides | 2 | 2023 | 107 | 0.390 |
Why?
| | Intraocular Pressure | 3 | 2025 | 307 | 0.380 |
Why?
| | Mass Spectrometry | 6 | 2019 | 739 | 0.380 |
Why?
| | Paraffin Embedding | 2 | 2024 | 32 | 0.380 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 6 | 2018 | 345 | 0.370 |
Why?
| | Protein Conformation | 7 | 2019 | 934 | 0.370 |
Why?
| | Interferon-gamma | 3 | 2018 | 789 | 0.370 |
Why?
| | Organ Culture Techniques | 5 | 2019 | 156 | 0.360 |
Why?
| | Water | 3 | 2023 | 460 | 0.360 |
Why?
| | Caspase 3 | 5 | 2013 | 246 | 0.360 |
Why?
| | HeLa Cells | 4 | 2016 | 636 | 0.350 |
Why?
| | Citrate (si)-Synthase | 4 | 2020 | 60 | 0.350 |
Why?
| | Protein Binding | 6 | 2020 | 2224 | 0.350 |
Why?
| | Middle Aged | 24 | 2024 | 33479 | 0.350 |
Why?
| | Proto-Oncogene Proteins c-fyn | 1 | 2010 | 12 | 0.340 |
Why?
| | Aquaporins | 1 | 2010 | 8 | 0.340 |
Why?
| | Caspase 9 | 4 | 2013 | 57 | 0.330 |
Why?
| | Myristic Acid | 2 | 2010 | 10 | 0.330 |
Why?
| | Fibroblast Growth Factor 2 | 1 | 2010 | 87 | 0.320 |
Why?
| | Protein Denaturation | 4 | 2020 | 74 | 0.320 |
Why?
| | Membrane Lipids | 1 | 2010 | 91 | 0.320 |
Why?
| | Apoptosis Regulatory Proteins | 2 | 2010 | 188 | 0.320 |
Why?
| | Gene Expression Regulation | 2 | 2019 | 2607 | 0.320 |
Why?
| | Rats, Sprague-Dawley | 8 | 2015 | 2486 | 0.300 |
Why?
| | Actins | 3 | 2020 | 416 | 0.300 |
Why?
| | Protein Folding | 1 | 2010 | 280 | 0.290 |
Why?
| | Norleucine | 4 | 1996 | 4 | 0.290 |
Why?
| | Molecular Sequence Data | 5 | 2015 | 2900 | 0.290 |
Why?
| | Aldehyde Reductase | 4 | 2006 | 29 | 0.290 |
Why?
| | gamma-Crystallins | 2 | 2020 | 3 | 0.280 |
Why?
| | Structure-Activity Relationship | 4 | 2015 | 570 | 0.280 |
Why?
| | Endothelium, Vascular | 3 | 2004 | 927 | 0.280 |
Why?
| | Signal Transduction | 5 | 2025 | 5079 | 0.270 |
Why?
| | Cloning, Molecular | 4 | 2010 | 534 | 0.270 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2008 | 283 | 0.270 |
Why?
| | Reactive Oxygen Species | 7 | 2018 | 622 | 0.270 |
Why?
| | Adult | 23 | 2020 | 37929 | 0.270 |
Why?
| | Cricetulus | 3 | 2013 | 109 | 0.260 |
Why?
| | Lens Diseases | 1 | 2006 | 2 | 0.260 |
Why?
| | CHO Cells | 3 | 2013 | 161 | 0.260 |
Why?
| | Cricetinae | 3 | 2013 | 289 | 0.260 |
Why?
| | Hyperglycemia | 3 | 2012 | 347 | 0.250 |
Why?
| | Dipeptides | 1 | 2005 | 50 | 0.240 |
Why?
| | Dose-Response Relationship, Drug | 5 | 2013 | 2057 | 0.240 |
Why?
| | Enzyme Activation | 4 | 2010 | 810 | 0.240 |
Why?
| | Cytokines | 1 | 2013 | 2085 | 0.240 |
Why?
| | Molecular Structure | 6 | 2012 | 489 | 0.240 |
Why?
| | Quinoxalines | 1 | 2005 | 66 | 0.240 |
Why?
| | Galactosemias | 3 | 2000 | 16 | 0.240 |
Why?
| | Cell Cycle | 1 | 2008 | 601 | 0.230 |
Why?
| | Alkylation | 1 | 2025 | 26 | 0.230 |
Why?
| | GAP-43 Protein | 1 | 2025 | 6 | 0.230 |
Why?
| | Synapsins | 1 | 2025 | 14 | 0.230 |
Why?
| | Histidine | 1 | 2005 | 64 | 0.230 |
Why?
| | Serum Albumin | 2 | 2008 | 150 | 0.230 |
Why?
| | Cell-Penetrating Peptides | 1 | 2025 | 21 | 0.230 |
Why?
| | Mice, Inbred BALB C | 3 | 2019 | 1272 | 0.230 |
Why?
| | Laser Coagulation | 1 | 2025 | 68 | 0.230 |
Why?
| | Diabetes Complications | 1 | 2006 | 227 | 0.230 |
Why?
| | Retinal Pigment Epithelium | 1 | 2025 | 77 | 0.230 |
Why?
| | Protein Transport | 3 | 2015 | 445 | 0.230 |
Why?
| | Magnetic Resonance Spectroscopy | 7 | 2007 | 611 | 0.230 |
Why?
| | Acetyl Coenzyme A | 1 | 2024 | 5 | 0.220 |
Why?
| | Down-Regulation | 3 | 2013 | 657 | 0.220 |
Why?
| | Benzamides | 1 | 2025 | 216 | 0.220 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 1 | 2025 | 145 | 0.220 |
Why?
| | Protein Aggregates | 2 | 2015 | 72 | 0.220 |
Why?
| | Formaldehyde | 1 | 2024 | 63 | 0.220 |
Why?
| | Mutation | 3 | 2015 | 3958 | 0.220 |
Why?
| | Protein Kinase C | 1 | 2005 | 261 | 0.210 |
Why?
| | Glomerular Mesangium | 1 | 2003 | 21 | 0.210 |
Why?
| | Neuroprotective Agents | 1 | 2025 | 131 | 0.210 |
Why?
| | Tomography, Optical Coherence | 1 | 2025 | 213 | 0.210 |
Why?
| | Calmodulin | 1 | 2003 | 76 | 0.210 |
Why?
| | Axonal Transport | 2 | 2022 | 27 | 0.200 |
Why?
| | Antimicrobial Cationic Peptides | 1 | 2003 | 81 | 0.200 |
Why?
| | Proline | 1 | 2003 | 79 | 0.200 |
Why?
| | Amine Oxidase (Copper-Containing) | 1 | 2002 | 5 | 0.200 |
Why?
| | Imidazolidines | 2 | 1994 | 10 | 0.200 |
Why?
| | Neuroprotection | 1 | 2022 | 42 | 0.190 |
Why?
| | Temperature | 2 | 2020 | 679 | 0.190 |
Why?
| | Amino Acids | 4 | 2017 | 497 | 0.190 |
Why?
| | Ribose | 3 | 2017 | 23 | 0.190 |
Why?
| | Oxidation-Reduction | 2 | 2017 | 1060 | 0.180 |
Why?
| | Capsulorhexis | 1 | 2021 | 8 | 0.180 |
Why?
| | Cytochromes c | 2 | 2013 | 60 | 0.180 |
Why?
| | Age Factors | 4 | 2019 | 3295 | 0.180 |
Why?
| | Male | 15 | 2025 | 67762 | 0.180 |
Why?
| | Acetone | 1 | 2001 | 11 | 0.180 |
Why?
| | Oxidative Stress | 2 | 2005 | 1317 | 0.180 |
Why?
| | Recombinant Proteins | 3 | 2012 | 1353 | 0.180 |
Why?
| | Malate Dehydrogenase | 1 | 2020 | 1 | 0.170 |
Why?
| | Beer | 1 | 2001 | 12 | 0.170 |
Why?
| | Fluorescence | 5 | 2015 | 160 | 0.170 |
Why?
| | Epitopes | 2 | 2005 | 479 | 0.170 |
Why?
| | Models, Molecular | 4 | 2017 | 1570 | 0.170 |
Why?
| | Anti-Infective Agents | 1 | 2003 | 255 | 0.170 |
Why?
| | Mutagenesis, Site-Directed | 4 | 2015 | 375 | 0.170 |
Why?
| | Lipids | 1 | 2005 | 672 | 0.170 |
Why?
| | Diabetic Nephropathies | 1 | 2024 | 294 | 0.170 |
Why?
| | Phosphorylation | 6 | 2010 | 1759 | 0.170 |
Why?
| | Diabetic Angiopathies | 1 | 2002 | 259 | 0.170 |
Why?
| | Mice, 129 Strain | 1 | 2020 | 88 | 0.160 |
Why?
| | Excitatory Amino Acid Antagonists | 1 | 2020 | 100 | 0.160 |
Why?
| | Muscle, Smooth, Vascular | 1 | 2002 | 446 | 0.160 |
Why?
| | Mice, Transgenic | 3 | 2010 | 2167 | 0.160 |
Why?
| | Oxalates | 1 | 1999 | 10 | 0.160 |
Why?
| | Thermodynamics | 2 | 2012 | 407 | 0.160 |
Why?
| | Blood Glucose | 3 | 2021 | 2186 | 0.160 |
Why?
| | Antibody Specificity | 3 | 2009 | 189 | 0.160 |
Why?
| | Adolescent | 10 | 2020 | 21513 | 0.150 |
Why?
| | Multiprotein Complexes | 1 | 2020 | 163 | 0.150 |
Why?
| | Succinates | 1 | 2019 | 22 | 0.150 |
Why?
| | Spectrophotometry | 4 | 2005 | 61 | 0.150 |
Why?
| | Cytoskeletal Proteins | 1 | 2019 | 158 | 0.150 |
Why?
| | Cytosol | 1 | 2019 | 226 | 0.150 |
Why?
| | Aged, 80 and over | 10 | 2015 | 7635 | 0.150 |
Why?
| | Gain of Function Mutation | 1 | 2019 | 36 | 0.150 |
Why?
| | Membrane Proteins | 2 | 2019 | 1164 | 0.150 |
Why?
| | Tumor Cells, Cultured | 1 | 2020 | 955 | 0.150 |
Why?
| | Young Adult | 4 | 2020 | 13209 | 0.150 |
Why?
| | Retinal Degeneration | 1 | 2018 | 38 | 0.140 |
Why?
| | Binding Sites | 2 | 2012 | 1303 | 0.140 |
Why?
| | CD55 Antigens | 1 | 2017 | 30 | 0.140 |
Why?
| | Kinetics | 3 | 2012 | 1670 | 0.140 |
Why?
| | Calcium | 1 | 2003 | 1199 | 0.140 |
Why?
| | Mitochondrial Proteins | 1 | 2019 | 257 | 0.130 |
Why?
| | Collagen | 3 | 1996 | 452 | 0.130 |
Why?
| | Antioxidants | 2 | 2015 | 584 | 0.130 |
Why?
| | Deoxyglucose | 2 | 1996 | 53 | 0.130 |
Why?
| | Dura Mater | 2 | 1996 | 34 | 0.130 |
Why?
| | Snail Family Transcription Factors | 1 | 2016 | 17 | 0.130 |
Why?
| | Monosaccharides | 3 | 2003 | 12 | 0.130 |
Why?
| | Smad3 Protein | 1 | 2016 | 43 | 0.130 |
Why?
| | Basement Membrane | 1 | 2016 | 35 | 0.120 |
Why?
| | Smad2 Protein | 1 | 2016 | 38 | 0.120 |
Why?
| | Caproates | 1 | 1995 | 4 | 0.120 |
Why?
| | Smad4 Protein | 1 | 2016 | 38 | 0.120 |
Why?
| | Models, Chemical | 3 | 2005 | 263 | 0.120 |
Why?
| | Microscopy, Fluorescence | 2 | 2008 | 402 | 0.120 |
Why?
| | Selenious Acid | 1 | 2015 | 3 | 0.120 |
Why?
| | Nitric Oxide | 2 | 2013 | 915 | 0.120 |
Why?
| | Binding, Competitive | 3 | 2008 | 202 | 0.110 |
Why?
| | Photobleaching | 1 | 2015 | 23 | 0.110 |
Why?
| | Proto-Oncogene Proteins c-akt | 2 | 2010 | 437 | 0.110 |
Why?
| | Injections, Intraperitoneal | 1 | 2015 | 114 | 0.110 |
Why?
| | Dimerization | 2 | 2007 | 199 | 0.110 |
Why?
| | Models, Biological | 3 | 2010 | 1783 | 0.110 |
Why?
| | Stereoisomerism | 2 | 2005 | 96 | 0.110 |
Why?
| | Caspases | 2 | 2006 | 247 | 0.110 |
Why?
| | Heat-Shock Response | 1 | 2015 | 77 | 0.110 |
Why?
| | Glycoproteins | 1 | 1996 | 342 | 0.110 |
Why?
| | Peroxynitrous Acid | 1 | 2013 | 13 | 0.110 |
Why?
| | NG-Nitroarginine Methyl Ester | 1 | 2013 | 48 | 0.110 |
Why?
| | RNA, Messenger | 2 | 2016 | 2833 | 0.110 |
Why?
| | Glycine | 1 | 2014 | 176 | 0.110 |
Why?
| | Proto-Oncogene Proteins | 2 | 2010 | 648 | 0.100 |
Why?
| | Cell Movement | 1 | 2018 | 967 | 0.100 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2013 | 173 | 0.100 |
Why?
| | Time Factors | 5 | 2006 | 6828 | 0.100 |
Why?
| | Algorithms | 1 | 2021 | 1704 | 0.100 |
Why?
| | Flow Cytometry | 2 | 2008 | 1178 | 0.100 |
Why?
| | RNA | 1 | 2019 | 921 | 0.090 |
Why?
| | Enzyme Inhibitors | 2 | 2010 | 840 | 0.090 |
Why?
| | Acetic Anhydrides | 1 | 2011 | 3 | 0.090 |
Why?
| | Amino Acid Motifs | 1 | 2012 | 225 | 0.090 |
Why?
| | Extracellular Matrix | 1 | 2016 | 528 | 0.090 |
Why?
| | Transfection | 2 | 2004 | 945 | 0.090 |
Why?
| | Biomarkers | 3 | 2016 | 4149 | 0.090 |
Why?
| | Ribonuclease, Pancreatic | 2 | 2005 | 12 | 0.090 |
Why?
| | RNA Interference | 1 | 2013 | 469 | 0.090 |
Why?
| | Microscopy, Confocal | 2 | 2004 | 325 | 0.090 |
Why?
| | Chromatography, Gel | 2 | 2005 | 127 | 0.090 |
Why?
| | Cell Membrane | 2 | 2005 | 738 | 0.090 |
Why?
| | Interleukin-1beta | 1 | 2013 | 372 | 0.090 |
Why?
| | Mutant Proteins | 1 | 2011 | 103 | 0.090 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 976 | 0.090 |
Why?
| | Cell Nucleus | 1 | 2015 | 620 | 0.090 |
Why?
| | Stress, Physiological | 1 | 2015 | 443 | 0.090 |
Why?
| | Dogs | 3 | 2005 | 413 | 0.090 |
Why?
| | Glutamine | 1 | 2011 | 103 | 0.090 |
Why?
| | Insulin | 3 | 2008 | 2409 | 0.090 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2012 | 385 | 0.090 |
Why?
| | Base Sequence | 2 | 2015 | 2181 | 0.090 |
Why?
| | Guanidines | 3 | 2000 | 39 | 0.090 |
Why?
| | Inflammation Mediators | 1 | 2013 | 513 | 0.080 |
Why?
| | Drug Antagonism | 1 | 2010 | 10 | 0.080 |
Why?
| | Oncogene Protein v-akt | 1 | 2010 | 24 | 0.080 |
Why?
| | Female | 11 | 2024 | 73304 | 0.080 |
Why?
| | Spectrophotometry, Ultraviolet | 1 | 2010 | 86 | 0.080 |
Why?
| | Bcl-2-Like Protein 11 | 1 | 2010 | 38 | 0.080 |
Why?
| | Resins, Synthetic | 1 | 2009 | 14 | 0.080 |
Why?
| | Buffers | 1 | 2009 | 56 | 0.080 |
Why?
| | Edetic Acid | 1 | 2009 | 50 | 0.080 |
Why?
| | Phosphatidylinositol 3-Kinase | 1 | 2010 | 26 | 0.080 |
Why?
| | bcl-2-Associated X Protein | 1 | 2010 | 56 | 0.080 |
Why?
| | Caspase Inhibitors | 1 | 2010 | 81 | 0.080 |
Why?
| | Alzheimer Disease | 3 | 2010 | 560 | 0.080 |
Why?
| | Complement System Proteins | 1 | 2012 | 327 | 0.080 |
Why?
| | DNA Primers | 1 | 2010 | 515 | 0.080 |
Why?
| | Surface Properties | 1 | 2010 | 413 | 0.080 |
Why?
| | In Vitro Techniques | 2 | 2009 | 1092 | 0.070 |
Why?
| | Umbilical Veins | 2 | 2008 | 62 | 0.070 |
Why?
| | Myosin Type II | 1 | 2008 | 17 | 0.070 |
Why?
| | PTEN Phosphohydrolase | 1 | 2010 | 167 | 0.070 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2013 | 1242 | 0.070 |
Why?
| | Homoarginine | 1 | 2008 | 2 | 0.070 |
Why?
| | Methylurea Compounds | 1 | 2008 | 7 | 0.070 |
Why?
| | Oxygen | 2 | 2005 | 931 | 0.070 |
Why?
| | Hydrogen Peroxide | 1 | 2009 | 328 | 0.070 |
Why?
| | Antibodies | 2 | 2000 | 410 | 0.070 |
Why?
| | Doxorubicin | 1 | 2010 | 362 | 0.070 |
Why?
| | Intercellular Adhesion Molecule-1 | 2 | 2024 | 139 | 0.070 |
Why?
| | Serum Albumin, Bovine | 3 | 2000 | 64 | 0.070 |
Why?
| | Macular Degeneration | 1 | 2009 | 164 | 0.070 |
Why?
| | Receptors, Immunologic | 1 | 2008 | 216 | 0.070 |
Why?
| | Uremia | 3 | 2008 | 16 | 0.070 |
Why?
| | Frameshift Mutation | 1 | 2007 | 32 | 0.070 |
Why?
| | Autoantibodies | 2 | 2012 | 1496 | 0.070 |
Why?
| | Fatty Acids | 1 | 2010 | 443 | 0.070 |
Why?
| | Polymerase Chain Reaction | 1 | 2010 | 1062 | 0.070 |
Why?
| | Protein Subunits | 1 | 2008 | 239 | 0.070 |
Why?
| | Rabbits | 2 | 1998 | 794 | 0.070 |
Why?
| | Spectrometry, Mass, Fast Atom Bombardment | 2 | 1996 | 8 | 0.060 |
Why?
| | Carbonic Anhydrases | 1 | 2006 | 14 | 0.060 |
Why?
| | Nitroso Compounds | 1 | 2006 | 7 | 0.060 |
Why?
| | Nitric Oxide Donors | 1 | 2006 | 21 | 0.060 |
Why?
| | Hemocyanins | 1 | 2005 | 62 | 0.060 |
Why?
| | Amino Acid Substitution | 1 | 2007 | 307 | 0.060 |
Why?
| | Iodides | 1 | 2005 | 8 | 0.060 |
Why?
| | Myristic Acids | 1 | 2005 | 8 | 0.060 |
Why?
| | Sweetening Agents | 1 | 2006 | 54 | 0.060 |
Why?
| | Ninhydrin | 1 | 2005 | 1 | 0.060 |
Why?
| | Fructose | 1 | 2005 | 112 | 0.060 |
Why?
| | Diffusion | 1 | 2005 | 116 | 0.060 |
Why?
| | Rats, Inbred BN | 1 | 2025 | 58 | 0.060 |
Why?
| | Cytoplasm | 1 | 2005 | 274 | 0.060 |
Why?
| | Reference Values | 3 | 1997 | 816 | 0.060 |
Why?
| | Tissue Fixation | 1 | 2024 | 36 | 0.060 |
Why?
| | Cell Differentiation | 2 | 2010 | 1991 | 0.060 |
Why?
| | Erythrocytes | 2 | 2017 | 700 | 0.060 |
Why?
| | Magnesium Oxide | 1 | 2024 | 1 | 0.060 |
Why?
| | Ependymoglial Cells | 1 | 2024 | 8 | 0.050 |
Why?
| | Acetylcysteine | 1 | 2005 | 145 | 0.050 |
Why?
| | CD40 Ligand | 1 | 2024 | 41 | 0.050 |
Why?
| | Laminin | 1 | 2024 | 72 | 0.050 |
Why?
| | Anilino Naphthalenesulfonates | 1 | 2003 | 10 | 0.050 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2005 | 177 | 0.050 |
Why?
| | Alcohol Dehydrogenase | 1 | 2003 | 15 | 0.050 |
Why?
| | Cytochrome c Group | 1 | 2003 | 43 | 0.050 |
Why?
| | CD40 Antigens | 1 | 2024 | 89 | 0.050 |
Why?
| | Phosphodiesterase Inhibitors | 1 | 2003 | 89 | 0.050 |
Why?
| | Reproducibility of Results | 1 | 2011 | 3284 | 0.050 |
Why?
| | Antigens | 1 | 2005 | 357 | 0.050 |
Why?
| | Mitochondria | 1 | 2010 | 948 | 0.050 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2004 | 283 | 0.050 |
Why?
| | Galectin 3 | 1 | 2003 | 20 | 0.050 |
Why?
| | Up-Regulation | 1 | 2006 | 843 | 0.050 |
Why?
| | Semicarbazides | 1 | 2002 | 1 | 0.050 |
Why?
| | Kidney Glomerulus | 1 | 2003 | 119 | 0.050 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2004 | 313 | 0.050 |
Why?
| | Thiobarbituric Acid Reactive Substances | 1 | 2002 | 30 | 0.050 |
Why?
| | Retinal Neovascularization | 1 | 2002 | 25 | 0.050 |
Why?
| | Oligopeptides | 1 | 2004 | 271 | 0.050 |
Why?
| | Child | 4 | 2015 | 21935 | 0.050 |
Why?
| | Deoxyribose | 1 | 2001 | 6 | 0.040 |
Why?
| | Carbohydrate Metabolism | 1 | 2001 | 59 | 0.040 |
Why?
| | Serum Albumin, Human | 1 | 2000 | 6 | 0.040 |
Why?
| | Molecular Weight | 2 | 1991 | 335 | 0.040 |
Why?
| | Color | 1 | 2001 | 76 | 0.040 |
Why?
| | Cell Proliferation | 1 | 2008 | 2475 | 0.040 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2001 | 132 | 0.040 |
Why?
| | Carbohydrates | 1 | 2000 | 65 | 0.040 |
Why?
| | Muramidase | 1 | 2000 | 78 | 0.040 |
Why?
| | Chelating Agents | 1 | 2000 | 75 | 0.040 |
Why?
| | Aldehydes | 1 | 2001 | 145 | 0.040 |
Why?
| | Aorta | 1 | 2002 | 417 | 0.040 |
Why?
| | Alkanes | 1 | 1999 | 13 | 0.040 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 1999 | 144 | 0.040 |
Why?
| | Galactose | 2 | 2000 | 33 | 0.040 |
Why?
| | Fluorescent Antibody Technique, Indirect | 1 | 1998 | 51 | 0.040 |
Why?
| | Amides | 1 | 1999 | 93 | 0.040 |
Why?
| | Analysis of Variance | 1 | 2001 | 1316 | 0.040 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2003 | 860 | 0.040 |
Why?
| | Glyceraldehyde | 1 | 1997 | 2 | 0.030 |
Why?
| | Inclusion Bodies | 1 | 1997 | 28 | 0.030 |
Why?
| | Neurosciences | 1 | 1997 | 25 | 0.030 |
Why?
| | Photosensitizing Agents | 1 | 1997 | 41 | 0.030 |
Why?
| | Catalytic Domain | 1 | 2017 | 207 | 0.030 |
Why?
| | Amyloid | 1 | 1997 | 87 | 0.030 |
Why?
| | Glycosuria | 1 | 1996 | 9 | 0.030 |
Why?
| | Kidney | 1 | 2024 | 1468 | 0.030 |
Why?
| | Immunoglobulin G | 2 | 2012 | 893 | 0.030 |
Why?
| | Aminocaproates | 1 | 1995 | 2 | 0.030 |
Why?
| | Ethers | 1 | 1996 | 19 | 0.030 |
Why?
| | Neurofilament Proteins | 1 | 1996 | 52 | 0.030 |
Why?
| | Scattering, Radiation | 1 | 2015 | 101 | 0.030 |
Why?
| | Protein Unfolding | 1 | 2014 | 31 | 0.030 |
Why?
| | Galactitol | 1 | 1994 | 1 | 0.030 |
Why?
| | Complement Activation | 1 | 2017 | 415 | 0.030 |
Why?
| | Lymphocyte Activation | 1 | 2017 | 1142 | 0.030 |
Why?
| | Sodium-Potassium-Exchanging ATPase | 1 | 1993 | 49 | 0.020 |
Why?
| | ADP-ribosyl Cyclase 1 | 1 | 2012 | 38 | 0.020 |
Why?
| | Pronase | 1 | 1992 | 5 | 0.020 |
Why?
| | Child, Preschool | 1 | 2007 | 11074 | 0.020 |
Why?
| | Serum | 1 | 2012 | 59 | 0.020 |
Why?
| | Diabetic Neuropathies | 1 | 1993 | 94 | 0.020 |
Why?
| | Case-Control Studies | 2 | 2010 | 3556 | 0.020 |
Why?
| | Hydrolysis | 1 | 1991 | 177 | 0.020 |
Why?
| | Pigmentation | 1 | 1991 | 52 | 0.020 |
Why?
| | Rats, Inbred Strains | 1 | 1990 | 362 | 0.020 |
Why?
| | Immune Tolerance | 1 | 2012 | 363 | 0.020 |
Why?
| | Fluorometry | 1 | 2009 | 17 | 0.020 |
Why?
| | Autoantigens | 1 | 2012 | 430 | 0.020 |
Why?
| | NADPH Oxidase 4 | 1 | 2008 | 8 | 0.020 |
Why?
| | NADPH Oxidase 2 | 1 | 2008 | 39 | 0.020 |
Why?
| | Vascular Cell Adhesion Molecule-1 | 1 | 2008 | 39 | 0.020 |
Why?
| | NADPH Oxidases | 1 | 2008 | 113 | 0.020 |
Why?
| | Diet | 1 | 1994 | 1278 | 0.020 |
Why?
| | Membrane Glycoproteins | 1 | 2008 | 500 | 0.020 |
Why?
| | NF-kappa B | 1 | 2008 | 691 | 0.010 |
Why?
| | Hippocampus | 1 | 2010 | 895 | 0.010 |
Why?
| | Amines | 2 | 1997 | 40 | 0.010 |
Why?
| | Logistic Models | 1 | 2009 | 2074 | 0.010 |
Why?
| | Endothelium, Corneal | 1 | 2003 | 16 | 0.010 |
Why?
| | Epiretinal Membrane | 1 | 2002 | 8 | 0.010 |
Why?
| | Retinal Vasculitis | 1 | 2002 | 10 | 0.010 |
Why?
| | Tissue Distribution | 1 | 2003 | 332 | 0.010 |
Why?
| | Immunoenzyme Techniques | 1 | 2002 | 219 | 0.010 |
Why?
| | Photochemistry | 1 | 2002 | 134 | 0.010 |
Why?
| | Cell Communication | 1 | 2003 | 315 | 0.010 |
Why?
| | Neurons | 1 | 2010 | 1590 | 0.010 |
Why?
| | In Situ Nick-End Labeling | 1 | 2000 | 124 | 0.010 |
Why?
| | Cell Survival | 1 | 2000 | 1120 | 0.010 |
Why?
| | Alkalies | 1 | 1996 | 5 | 0.010 |
Why?
| | Densitometry | 1 | 1996 | 36 | 0.010 |
Why?
| | Guanidine | 1 | 1996 | 21 | 0.010 |
Why?
| | Sodium Dodecyl Sulfate | 1 | 1996 | 26 | 0.010 |
Why?
| | Formates | 1 | 1996 | 13 | 0.010 |
Why?
| | Cell Fractionation | 1 | 1996 | 56 | 0.010 |
Why?
| | Endopeptidases | 1 | 1996 | 90 | 0.010 |
Why?
| | Urea | 1 | 1996 | 81 | 0.010 |
Why?
| | Hemostatics | 1 | 1996 | 52 | 0.010 |
Why?
| | Immunoblotting | 1 | 1996 | 308 | 0.010 |
Why?
| | Microscopy, Electron | 1 | 1996 | 443 | 0.010 |
Why?
| | Peritoneal Dialysis | 1 | 1996 | 97 | 0.010 |
Why?
| | Renal Dialysis | 1 | 1996 | 435 | 0.010 |
Why?
| | Extracellular Matrix Proteins | 1 | 1992 | 153 | 0.010 |
Why?
| | Axons | 1 | 1993 | 198 | 0.010 |
Why?
| | Kidney Failure, Chronic | 1 | 1996 | 570 | 0.010 |
Why?
| | Hydrogen-Ion Concentration | 1 | 1989 | 560 | 0.000 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 1993 | 2531 | 0.000 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 1993 | 3715 | 0.000 |
Why?
|
|
Nagaraj's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|